PTN Palatin Technologies Inc

Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical need and commercial potential.

$5.95  +0.03 (0.51%)
As of 10/03/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/07/2001
Outstanding shares:  9,290,481
Average volume:  152,726
Market cap:   $55,464,172
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2103781
Valuation   (See tab for details)
PE ratio:   -1.47
PB ratio:   48.93
PS ratio:   89.04
Return on equity:   -133.04%
Net income %:   -5,998.43%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy